HRP20120147T1 - Titracija tapentadola - Google Patents

Titracija tapentadola Download PDF

Info

Publication number
HRP20120147T1
HRP20120147T1 HR20120147T HRP20120147T HRP20120147T1 HR P20120147 T1 HRP20120147 T1 HR P20120147T1 HR 20120147 T HR20120147 T HR 20120147T HR P20120147 T HRP20120147 T HR P20120147T HR P20120147 T1 HRP20120147 T1 HR P20120147T1
Authority
HR
Croatia
Prior art keywords
dose
tapentadol
administration
administration interval
interval
Prior art date
Application number
HR20120147T
Other languages
English (en)
Croatian (hr)
Inventor
Lange Claudia
Rombout Ferdinand
Original Assignee
Grnenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20120147(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grnenthal Gmbh filed Critical Grnenthal Gmbh
Publication of HRP20120147T1 publication Critical patent/HRP20120147T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20120147T 2007-04-23 2012-02-15 Titracija tapentadola HRP20120147T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol
PCT/EP2008/003178 WO2008128740A1 (en) 2007-04-23 2008-04-21 Titration of tapentadol

Publications (1)

Publication Number Publication Date
HRP20120147T1 true HRP20120147T1 (hr) 2012-03-31

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120147T HRP20120147T1 (hr) 2007-04-23 2012-02-15 Titracija tapentadola

Country Status (22)

Country Link
US (4) US20090012180A1 (xx)
EP (5) EP1985292A1 (xx)
JP (4) JP5933176B2 (xx)
KR (3) KR20150027840A (xx)
CN (1) CN101730530B (xx)
AT (1) ATE534378T1 (xx)
AU (1) AU2008241013B2 (xx)
CA (1) CA2683786C (xx)
CY (1) CY1112320T1 (xx)
DK (1) DK2148670T3 (xx)
ES (1) ES2378255T3 (xx)
HK (1) HK1140940A1 (xx)
HR (1) HRP20120147T1 (xx)
IL (1) IL201479A (xx)
MX (1) MX2009011444A (xx)
NZ (1) NZ580415A (xx)
PL (1) PL2148670T3 (xx)
PT (1) PT2148670E (xx)
RU (1) RU2472497C2 (xx)
SI (1) SI2148670T1 (xx)
WO (1) WO2008128740A1 (xx)
ZA (1) ZA200907355B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
SI2352494T1 (sl) * 2008-10-30 2019-12-31 Gruenenthal Gmbh Nove in potentne dozirne oblike tapentadola
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) * 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2566461A2 (de) * 2010-05-05 2013-03-13 Ratiopharm GmbH Festes tapentadol in nicht-kristalliner form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
BR112012033644A2 (pt) * 2010-06-30 2016-11-22 Gruenenthal Gmbh tapentadol para uso no tratamento de síndrome do intestino irritável
EP3653600A1 (en) * 2010-07-23 2020-05-20 Grünenthal GmbH Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
EP3025710A1 (en) * 2011-03-04 2016-06-01 Grünenthal GmbH Parenteral administration of tapentadol
US9446008B2 (en) 2011-03-04 2016-09-20 Gruenenthal Gmbh Semisolid aqueous pharmaceutical composition containing tapentadol
EP3287123B1 (en) 2011-03-04 2020-04-22 Grünenthal GmbH Aqueous pharmaceutical formulation of tapentadol for oral administration
HUE047342T2 (hu) * 2011-04-05 2020-04-28 Gruenenthal Gmbh Tapentadol a trigeminális neuralgiával kapcsolatos fájdalom kezelése során történõ alkalmazásra
DK2694049T3 (da) * 2011-04-05 2019-01-02 Gruenenthal Gmbh Tapentadol til forebyggelse af kronificering af smerte
EP2701693B1 (en) 2011-04-29 2017-08-23 Grünenthal GmbH Tapentadol for preventing and treating depression and anxiety
US9301918B2 (en) * 2013-03-15 2016-04-05 Mallinckrodt Llc Abuse deterrent solid dosage form for immediate release with functional score
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
WO2016156147A1 (en) 2015-03-27 2016-10-06 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
ES2869981T3 (es) * 2015-05-26 2021-10-26 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Composiciones para su uso en el tratamiento de la enfermedad de parkinson y trastornos relacionados
WO2017148595A1 (en) 2016-02-29 2017-09-08 Grünenthal GmbH Titration of cebranopadol
PE20190908A1 (es) 2016-09-23 2019-06-26 Gruenenthal Chemie Formulacion estable para la administracion parenteral de tapentadol
EP4121013A1 (en) 2020-03-16 2023-01-25 Grünenthal GmbH Scored tablet
EP4308061A1 (en) * 2021-03-17 2024-01-24 Actelion Pharmaceuticals Ltd. Pharmaceutical dosage system
WO2022234076A1 (en) * 2021-05-07 2022-11-10 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
SI1572167T1 (sl) 2002-12-13 2008-12-31 Euro Celtique Sa Transdermalni buprenorfinski dozirni reĹľim za analgezijo
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
DE102007019417A1 (de) * 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose

Also Published As

Publication number Publication date
CN101730530B (zh) 2013-10-23
HK1140940A1 (en) 2010-10-29
EP1985292A1 (en) 2008-10-29
EP3143993A1 (en) 2017-03-22
AU2008241013B2 (en) 2013-06-20
PT2148670E (pt) 2012-01-24
US20160074342A1 (en) 2016-03-17
CY1112320T1 (el) 2015-12-09
WO2008128740A1 (en) 2008-10-30
JP2018030864A (ja) 2018-03-01
RU2472497C2 (ru) 2013-01-20
DK2148670T3 (da) 2012-03-12
EP3603630A1 (en) 2020-02-05
KR102078999B1 (ko) 2020-02-19
PL2148670T3 (pl) 2012-04-30
EP2422778A1 (en) 2012-02-29
US11344512B2 (en) 2022-05-31
ATE534378T1 (de) 2011-12-15
MX2009011444A (es) 2009-11-05
CA2683786A1 (en) 2008-10-30
US20190290603A1 (en) 2019-09-26
ES2378255T3 (es) 2012-04-10
CN101730530A (zh) 2010-06-09
US20170079938A1 (en) 2017-03-23
SI2148670T1 (sl) 2012-03-30
KR20150027840A (ko) 2015-03-12
EP2148670A1 (en) 2010-02-03
CA2683786C (en) 2021-10-26
KR20180004839A (ko) 2018-01-12
IL201479A (en) 2016-04-21
JP2019131598A (ja) 2019-08-08
AU2008241013A1 (en) 2008-10-30
RU2009142940A (ru) 2011-05-27
EP2148670B1 (en) 2011-11-23
KR20100017267A (ko) 2010-02-16
US20090012180A1 (en) 2009-01-08
ZA200907355B (en) 2010-08-25
JP2010531296A (ja) 2010-09-24
JP2016128468A (ja) 2016-07-14
IL201479A0 (en) 2010-05-31
NZ580415A (en) 2012-04-27
JP5933176B2 (ja) 2016-06-08
WO2008128740A8 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
HRP20120147T1 (hr) Titracija tapentadola
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
BRPI0518266A2 (pt) medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular
JP2009102342A5 (xx)
MX2008010155A (es) Composiciones virucidales que contienen metal y sus usos.
RU2010140682A (ru) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
SI2501234T1 (en) METHODS AND INGREDIENTS FOR TREATMENT OF SYMPTOMS RELATED TO POST-TRAUMATIC STRESS EMISSIONS WITH THE USE OF CYCLOBENZAPRINE
JP2012533554A5 (xx)
RU2487707C2 (ru) Применение парацетамола и ибупрофена в лечении
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
JP2016505050A5 (xx)
JP2019529559A5 (xx)
UA57733C2 (uk) Спосіб профілактики відсроченого блювання та назальний аерозольний препарат метоклопраміду
ES2507570T3 (es) Terapia de combinación de Zn/trimetoprim
HRP20211661T1 (hr) Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti
US20080045482A1 (en) Compositions and methods for the treatment of viral infections
HRP20110225T1 (hr) Nova kombinacija lijekova kao antidepresivi
NZ703464A (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
UA112652C2 (uk) Фармацевтична композиція для лікування передчасної еякуляції і спосіб лікування передчасної еякуляції
RU2013124994A (ru) КОМБИНАЦИЯ БЕВАЦИЗУМАБА И 2,2-ДИМЕТИЛ-N-((S)-6-ОКСО-6,7-ДИГИДРО-5Н-ДИБЕНЗО[b,d]АЗЕПИН-7-ИЛ)-N'-(2,2,3,3,3-ПЕНТАФТОР-ПРОПИЛ)-МАЛОНАМИДА ДЛЯ ЛЕЧЕНИЯ ПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
DESAI et al. Hydroxychloroquine-A Saviour from The Past-A Review